Structure Therapeutics Inc.
GPCR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $398 | $993 | $1,554 |
| - Cash | $103 | $147 | $152 | $170 |
| + Debt | $4 | $8 | $8 | $4 |
| Enterprise Value | – | $259 | $848 | $1,388 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$65 | -$70 | -$56 | -$47 |
| % Margin | – | – | – | – |
| Net Income | -$66 | -$62 | -$47 | -$36 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.11 | -1.08 | -0.81 | -0.63 |
| % Growth | -2.8% | -33.3% | -28.6% | – |
| Operating Cash Flow | -$51 | -$55 | -$52 | -$36 |
| Capital Expenditures | -$2 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$53 | -$55 | -$53 | -$36 |